DS
LRMR icon

David Shaw’s Larimar Therapeutics LRMR Stock Holding History

David Shaw’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-575,624
Closed -$2.59M – 5068
2026
Q1 		$2.59M Buy
575,624
+138,225
+32% +$552K ﹤0.01% 2715
2025
Q4 		$1.67M Buy
+437,399
New +$1.7M ﹤0.01% 3193
2024
Q4 		– Sell
-16,122
Closed -$106K – 4660
2024
Q3 		$106K Buy
+16,122
New +$130K ﹤0.01% 4245
2019
Q4 		– Sell
-20,322
Closed -$180K – 4078
2019
Q3 		$180K Buy
20,322
+11,890
+141% +$130K ﹤0.01% 3642
2019
Q2 		$121K Sell
8,432
-2,552
-23% -$68K ﹤0.01% 3532
2019
Q1 		$361K Sell
10,984
-1,436
-12% -$73.6K ﹤0.01% 3139
2018
Q4 		$738K Sell
12,420
-9,488
-43% -$937K ﹤0.01% 2861
2018
Q3 		$3.07M Sell
21,908
-7,105
-24% -$862K ﹤0.01% 1902
2018
Q2 		$3.56M Sell
29,013
-3,779
-12% -$321K ﹤0.01% 1777
2018
Q1 		$2.93M Sell
32,792
-3,251
-9% -$276K ﹤0.01% 1765
2017
Q4 		$2M Sell
36,043
-3,343
-8% -$151K ﹤0.01% 2143
2017
Q3 		$1.66M Buy
39,386
+2,407
+7% +$100K ﹤0.01% 2161
2017
Q2 		$1.56M Sell
36,979
-5,328
-13% -$272K ﹤0.01% 2135
2017
Q1 		$2.37M Buy
42,307
+4,604
+12% +$229K ﹤0.01% 1733
2016
Q4 		$1.44M Buy
37,703
+6,513
+21% +$264K ﹤0.01% 2245
2016
Q3 		$1.24M Sell
31,190
-3,835
-11% -$174K ﹤0.01% 2258
2016
Q2 		$2.52M Buy
35,025
+7,069
+25% +$559K ﹤0.01% 1761
2016
Q1 		$2.24M Buy
+27,956
New +$2.21M ﹤0.01% 1803
2015
Q3 		– Sell
-731
Closed -$304K – 3819
2015
Q2 		$304K Buy
+731
New +$306K ﹤0.01% 3411

Other funds holding LRMR

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

David Shaw's LRMR Position: Q2 2026 in Review

David Shaw sold out of Larimar Therapeutics (LRMR) in Q2 2026, closing a stake of 575,624 shares — an estimated $2.59M sold.

David Shaw first reported a position in LRMR in Q2 2015 and held it in 19 quarters. The position peaked at $3.56M in Q2 2018. 161 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

  • David Shaw reported no remaining Larimar Therapeutics position as of Q2 2026 after selling out during the quarter.
  • David Shaw sold 575,624 Larimar Therapeutics shares in Q2 2026, an estimated $2.59M.
  • David Shaw first reported a position in Larimar Therapeutics in Q2 2015 and held it in 19 quarters.
  • David Shaw's Larimar Therapeutics position peaked at $3.56M in Q2 2018.
  • 161 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.